SCHEMBL5370523

SCHEMBL5370523

O=C(c1ccc(O)cc1)C1CCC(C(=O)c2ccc(O)cc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 5/20 0.57
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
ESR1 P03372 1/20 0.50
ESR2 Q92731 1/20 0.50
LMNA P02545 1/20 0.50
MAPT P10636 1/20 0.50
PKM P14618 1/20 0.50
HPGD P15428 1/20 0.50
HTT P42858 1/20 0.50
SRD5A2 P31213 1/20 0.50
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
CYP2D6 P10635 1/20 0.48
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CA12 O43570 1/20 0.48
CA3 P07451 1/20 0.48
TYR P14679 1/20 0.48
DRD1 P21728 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1334195 1.00 MGLL (0.57) MGLLNPC1RAB9AESR1ESR2
SCHEMBL5370517 1.00 MGLL (0.57) MGLLNPC1RAB9AESR1ESR2
Water SCHEMBL6848223 0.96 MGLL (0.54) MGLLNPC1RAB9AESR1ESR2
SCHEMBL1335827 0.91 SRD5A2 (0.56) MGLLNPC1RAB9AESR1ESR2
SCHEMBL1334288 0.91 SRD5A2 (0.61) MGLLNPC1RAB9AESR1ESR2
SCHEMBL7486159 0.89 SRD5A2 (0.65) MGLLNPC1RAB9AESR1ESR2
SCHEMBL9136087 0.89 SRD5A2 (0.65) MGLLNPC1RAB9AESR1ESR2
SCHEMBL31574435 0.86 HTT (0.50) MGLLNPC1RAB9AESR1ESR2
SCHEMBL5218517 0.86 MEN1 (0.69) MGLLNPC1RAB9ASRD5A2MEN1
Bromide SCHEMBL11614332 0.84 MEN1 (0.67) MGLLNPC1RAB9ASRD5A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7208551-B2 Polyaryleneetherketone phosphine oxide compositions incorporating cycloaliphatic units for use as polymeric binders in thermal control coatings and method for synthesizing same UNIVERSITY OF DAYTON (US) 2007-04-24 US claimed
US-20050043449-A1 Polyaryleneetherketone phosphine oxide compositions incorporating cycloaliphatic units for use as polymeric binders in thermal control coatings and method for synthesizing same UNIVERSITY OF DAYTON 2005-02-24 US claimed
US-7208551-B2 Polyaryleneetherketone phosphine oxide compositions incorporating cycloaliphatic units for use as polymeric binders in thermal control coatings and method for synthesizing same UNIVERSITY OF DAYTON (US) 2007-04-24 US disclosed
US-7208551-B2 Polyaryleneetherketone phosphine oxide compositions incorporating cycloaliphatic units for use as polymeric binders in thermal control coatings and method for synthesizing same UNIVERSITY OF DAYTON (US) 2007-04-24 US disclosed
US-7208551-B2 Polyaryleneetherketone phosphine oxide compositions incorporating cycloaliphatic units for use as polymeric binders in thermal control coatings and method for synthesizing same UNIVERSITY OF DAYTON (US) 2007-04-24 US disclosed
US-20050043449-A1 Polyaryleneetherketone phosphine oxide compositions incorporating cycloaliphatic units for use as polymeric binders in thermal control coatings and method for synthesizing same UNIVERSITY OF DAYTON 2005-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043449-A1 Polyaryleneetherketone phosphine oxide compositions incorporating cycloaliphatic units for use as polymeric binders in thermal control coatings and method for synthesizing same PNKP, PHOSPHO1, KTN1 MGLL 2362/4885NPC1 4238/4885RAB9A 3893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.